PEG coating reduces NMR relaxivity of Mn0.5Zn0.5Gd0.02Fe1.98O4 hyperthermia nanoparticles
暂无分享,去创建一个
R. Bowtell | Y. Haik | I. Obaidat | B. Issa | S. Qadri
[1] Jeremy Jones,et al. Superparamagnetism , 2013, Radiopaedia.org.
[2] O. Togao,et al. Off-resonance saturation magnetic resonance imaging of superparamagnetic polymeric micelles , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[3] N. Noginova,et al. NMR and spin relaxation in systems with magnetic nanoparticles: effects of size and molecular motion , 2009, Journal of physics. Condensed matter : an Institute of Physics journal.
[4] O. Togao,et al. Effect of PEG Corona Lengths on MR Relaxivity and Off-resonance Saturation Sensitivity of Superparamagnetic Polymeric Micelles , 2009 .
[5] S. Maenosono,et al. Superparamagnetic FePt nanoparticles as excellent MRI contrast agents , 2008 .
[6] Gang Bao,et al. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity , 2007, Journal of magnetic resonance imaging : JMRI.
[7] S. Franger,et al. Large influence of the synthesis conditions on the physico-chemical properties of nanostructured Fe3O4 , 2007 .
[8] C. Robic,et al. Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. , 2007, International journal of pharmaceutics.
[9] K. Uvdal,et al. High proton relaxivity for gadolinium oxide nanoparticles , 2006, Magnetic Resonance Materials in Physics, Biology and Medicine.
[10] You Qiang,et al. Iron/iron oxide core-shell nanoclusters for biomedical applications , 2006 .
[11] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[12] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[13] Jeff W M Bulte,et al. Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.
[14] S. Laurent,et al. Control of the synthesis of magnetic fluids by relaxometry and magnetometry , 2004 .
[15] V. Mohite. Self Controlled Magnetic Hyperthermia , 2004 .
[16] R. Brooks,et al. On T2‐shortening by strongly magnetized spheres: A partial refocusing model , 2002, Magnetic resonance in medicine.
[17] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[18] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[19] R. P. Pant,et al. Gd-substituted ferrite ferrofluid: a possible candidate to enhance pyromagnetic coefficient , 1999 .
[20] J. Bulte,et al. Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .
[21] V. Aswal,et al. CHARACTERIZATION OF A TEMPERATURE-SENSITIVE MAGNETIC FLUID , 1997 .
[22] S. Chikazumi. Physics of ferromagnetism , 1997 .
[23] Kinam Park,et al. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. , 1992, Biomaterials.
[24] S. H. Koenig,et al. Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite , 1987, Magnetic resonance in medicine.
[25] A. Giessen. Magnetic properties of ultra-fine iron (III) oxide-hydrate particles prepared from iroN (III) oxide-hydrate gels , 1966 .